Mostrar el registro sencillo del ítem
Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology
dc.contributor.author | Gómez Caamaño, Antonio | |
dc.contributor.author | González-San Segundo, C. | |
dc.contributor.author | Henríquez, I. | |
dc.contributor.author | Maldonado, X. | |
dc.contributor.author | Zapatero, A. | |
dc.date.accessioned | 2021-10-07T08:56:31Z | |
dc.date.available | 2021-10-07T08:56:31Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 1699-048X | |
dc.identifier.other | https://www.ncbi.nlm.nih.gov/pubmed/30293231 | es |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/15469 | |
dc.description.abstract | BACKGROUND: The knowledge in the field of castration-resistant prostate cancer (CRPC) is developing rapidly, with emerging new therapies and advances in imaging. Nonetheless, in multiple areas there is still a lack of or very limited evidence, and clear guidance from clinicians regarding optimal strategy is required. METHODS: A modified Delphi method, with 116 relevant questions divided into 7 different CRPC management topics, was used to develop a consensus statement by the URONCOR group. RESULTS: A strong consensus or unanimity was reached on 93% of the proposed questions. The seven topics addressed were: CRPC definition, symptomatic patients, diagnosis of metastasis, CRPC progression, M0 management, M1 management and sequencing therapy, and treatment monitoring. CONCLUSIONS: The recommendations based on the radiation oncology experts' opinions are intended to provide cancer specialists with expert guidance and to standardise CRPC patient management in Spain, facilitating decision-making in different clinically relevant issues regarding CRPC patients. | en |
dc.language.iso | eng | |
dc.rights | Atribución 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.title | Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology | es |
dc.type | Artigo | es |
dc.authorsophos | Gómez-Caamaño, A. | |
dc.authorsophos | González-San Segundo, C. | |
dc.authorsophos | Henríquez, I. | |
dc.authorsophos | Maldonado, X. | |
dc.authorsophos | Zapatero, A. | |
dc.identifier.doi | 10.1007/s12094-018-1940-2 | |
dc.identifier.pmid | 30293231 | |
dc.identifier.sophos | 30779 | |
dc.issue.number | 4 | es |
dc.journal.title | Clinical & Translational Oncology | es |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Oncoloxía Radioterápica | |
dc.page.initial | 420 | es |
dc.page.final | 432 | es |
dc.relation.publisherversion | https://link.springer.com/content/pdf/10.1007/s12094-018-1940-2.pdf | |
dc.rights.accessRights | openAccess | |
dc.subject.keyword | CHUS | |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | |
dc.typesophos | Artículo Original | |
dc.volume.number | 21 | es |